Roche Holding AG Logo

Roche Holding AG

A global leader in pharmaceuticals and diagnostics, pioneering personalized healthcare solutions.

RO | SW

Overview

Corporate Details

ISIN(s):
CH0012032048 (+1 more)
LEI:
549300U41AUUVOAAOB37
Country:
Switzerland
Address:
Grenzacherstr. 124, 4058 Basel
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Roche Holding AG is a global, research-based healthcare company operating through two primary divisions: Pharmaceuticals and Diagnostics. As one of the world's largest biotechnology companies, Roche is a leading provider of innovative cancer treatments and a key developer of medicines for viral infections and cardiometabolic diseases. The Diagnostics division focuses on providing in-vitro diagnostic tests and transformative solutions that support early detection, prevention, diagnosis, and treatment monitoring. By combining its strengths in both pharmaceuticals and diagnostics, Roche aims to advance personalized healthcare and improve patient outcomes worldwide through scientific innovation and digital health solutions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2004-12-31 00:00
Annual Report
Annual Report 2004
English 8.5 MB
2004-12-31 00:00
Annual Report
Jahresbericht 2004
German 8.8 MB
2004-04-22 00:00
Investor Presentation
Presentation to analysts First Quarter 2004 Basle, April 21, 2004
English 1.2 MB
2003-12-31 00:00
Annual Report
Annual Report 2003
English 8.4 MB
2003-12-31 00:00
Annual Report
Jahresbericht 2003
German 8.5 MB
2003-07-25 00:00
Investor Presentation
First Half 2003 Presentation to analysts
English 1.1 MB
2003-04-11 00:00
Investor Presentation
26 March 2003Roadshow USANew York
English 175.9 KB
2003-04-10 00:00
Investor Presentation
Company Presentation 2003
English 250.3 KB
2003-02-12 00:00
Investor Presentation
16 January 2003 Roadshow Germany
English 323.7 KB
2002-12-31 00:00
Annual Report
Annual Report 2002
English 9.3 MB
2002-12-31 00:00
Annual Report
Jahresbericht 2002
German 9.7 MB

Automate Your Workflow. Get a real-time feed of all Roche Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Roche Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Roche Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-16 N/A Executive member Sell None 1,494,248.20 CHF
2025-02-07 N/A Non-Executive member Buy None 613,652.00 CHF
2024-07-26 N/A Non-Executive member Sell None 1,743,760.00 CHF
2024-07-25 N/A Non-Executive member Sell None 723,460.00 CHF
2024-06-21 N/A Executive member Sell None 2,220,432.00 CHF
2024-06-10 N/A Executive member Sell None 1,260,138.00 CHF
2024-05-29 N/A Non-Executive member Buy None 504,400.00 CHF

Peer Companies

Chemical Works of Gedeon Richter Plc Logo
Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.
Hungary
RICHT
Chemomab Therapeutics Ltd. Logo
Develops antibody drugs neutralizing CCL24 for severe fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and sells prescription, OTC, and nutritional products for human use.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, produces, and sells advanced Traditional Chinese Medicine (TCM) herbal products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Global manufacturer of OTC medicines and health supplements distributed through pharmacies.
South Korea
034940
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan
4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden
CINPHA
Cingulate Inc. Logo
Developing once-daily, precision timed-release drugs for ADHD and anxiety.
United States of America
CING
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway
CRNA
CITIUS ONCOLOGY, INC. Logo
Commercializing LYMPHIR™, an FDA-approved targeted therapy for cutaneous T-cell lymphoma.
United States of America
CTOR

Talk to a Data Expert

Have a question? We'll get back to you promptly.